News
Inspired Advice: What Do You Need Most from a Life Partner?
Those who have faced an ovarian or gynecologic cancer diagnosis have so much to offer to others going through a similar experience – be it support, tips or friendship…
Speaking Out for Those Who Can’t | Meet an Advocate Leader
In 2005, Denise Lobodinski’s sister Renee was diagnosed with ovarian cancer at the age of 47. That same year, their father was diagnosed with prostate cancer. But her father’s doctor told Denise’s mother, “Don’t worry about your husband…
Survey: Navigating Treatment in the Time of Covid-19
Covid-19 has disrupted nearly every aspect of life as we know it, and navigating a diagnosis and treatment for ovarian cancer – already a game changer – has been impacted as well…
Science Made Simple: Ovarian Cysts and Ovarian Cancer
Ovarian cysts are fairly common, but that doesn’t make having them any less nerve-wracking. If you’ve been diagnosed with an ovarian cyst, it’s natural to wonder if that means you have, or are at risk of developing, ovarian cancer…
When a Virus is a Good Thing | Meet a Scientist
Scared. Overwhelmed. Exhausted. Befuddled. These are common words one might use to describe how we feel during this unprecedented time in history…
Reflections from the Frontline | OCRA Scientists on Covid-19
We reached out to our grantees and Scientific Advisory Committee, many of whom are on the frontlines – working in hospitals, meeting with patients, seeing firsthand the impact of Covid-19. We wanted to hear their words and reflections…
Raising Awareness of the Unseen, Giving Voice to the Unheard | Survivor Stories
The world works in ironic and sometimes painful ways Yvette Jives, a nurse and social worker in North Carolina, has spent a lifetime helping others…
Niraparib Receives FDA Approval as First-Line Maintenance Therapy for Advanced Ovarian Cancer
(May 4, 2020) On April 29th, the Food and Drug Administration approved niraparib (Zejula, GlaxoSmithKline) as a first-line maintenance treatment for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer, regardless of BRCA…
Update on OCRA’s 2020 Ovarian Cancer National Conference
(May 4, 2020) Many of you in our strong community have inquired about plans for our 2020 National Conference, originally scheduled for July 10-12 in Washington DC…
Making Calls and Taking Charge to Educate Others | Survivor Stories
Sandy Sullivan has a favorite quote that she keeps pinned to her bulletin board. It reads, “If you’re lucky enough to get a second chance at something, don’t waste it…
Science Made Simple: About Biopsies
Simply put, a biopsy is a surgical procedure that involves removing a piece of tissue, cell sample or fluid from part of the body, to determine if cancer cells are present…
We Need Your Support! #GivingTuesdayNow is May 5th
Nonprofits all over the world are hurting because of COVID-19…